Referências

1. Giustina A., Barkan A., Beckers A., Biermasz N., Biller B.M.K., Boguszewski C., Et al., A consen­sus on the diagnosis and treatment of acromegaly comorbidities: An update, J Clin Endocrinol Metab, 105, 4, (2020)
2. Colao A., Grasso L.F.S., Giustina A., Melmed S., Chanson P., Pereira A.M., Et al., Acromegaly. Nat Rev Dis Primers, 5, 1, (2019)
3. Chanson P., Vialon M., Caron P., An update on clinical care for pregnant women with acro­megaly, Expert Rev Endocrinol Metab, 14, 2, pp. 85-96, (2019)
4. Huang W., Molitch M.E., Pituitary tumors in pregnancy, Endocrinol Metab Clin N Am, 48, 3, pp. 569-581, (2019)
5. Petersenn S., Christ-Crain M., Droste M., Finke R., Flitsch J., Kreitschmann-Andermahr I., Et al., Pituitary disease in pregnancy: Special aspects of diagnosis and treatment?, Geburtshilfe Frauenheilkd, 79, 4, pp. 365-374, (2019)
6. Jallad R.S., Shimon I., Fraenkel M., Medvedovsky V., Akirov A., Duarte F.H., Et al., Outcome of preg­nancies in a large cohort of women with acromegaly, Clin Endocrinol, 88, 6, pp. 896-907, (2018)
7. Karaca Z., Yarman S., Ozbas I., Kadioglu P., Akturk M., Kilicli F., Et al., How does pregnancy affect the patients with pituitary adenomas: A study on 113 pregnancies from Turkey, J Endocrinol Investig, 41, 1, pp. 129-141, (2018)
8. Abucham J., Bronstein M.D., Dias M.L., Management of endocrine disease: Acromegaly and pregnancy: A contemporary review, Eur J Endocrinol, 177, 1, (2017)
9. Nomikos P., Buchfelder M., Fahlbusch R., The outcome of surgery in 668 patients with acro­megaly using current criteria of biochemical ‘cure’, Eur J Endocrinol, 152, 3, pp. 379-387, (2005)
10. Grynberg M., Salenave S., Young J., Chanson P., Female gonadal function before and after treat­ment of acromegaly, J Clin Endocrinol Metab, 95, 10, pp. 4518-4525, (2010)
11. Kaltsas G.A., Androulakis I.I., Tziveriotis K., Papadogias D., Tsikini A., Makras P., Et al., Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly, Clin Endocrinol, 67, 6, pp. 917-922, (2007)
12. Caron P., Broussaud S., Bertherat J., Borson-Chazot F., Brue T., Cortet-Rudelli C., Et al., Acromegaly and pregnancy: A retrospective multicenter study of 59 pregnancies in 46 women, J Clin Endocrinol Metab, 95, 10, pp. 4680-4687, (2010)
13. Montini M., Pagani G., Gianola D., Pagani M.D., Piolini R., Camboni M.G., Acromegaly and pri­mary amenorrhea: Ovulation and pregnancy induced by SMS 201-995 and bromocriptine, J Endocrinol Investig, 13, 2, (1990)
14. Guven S., Durukan T., Berker M., Basaran A., Saygan-Karamursel B., Palaoglu S., A case of acromegaly in pregnancy: Concomitant transsphenoidal adenomectomy and cesarean section, J Matern Fetal Neonatal Med, 19, 1, pp. 69-71, (2006)
15. Aono T., Shioji T., Kohno M., Ueda G., Kurachi K., Pregnancy following 2-bromo-alpha- ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea, Fertil Steril, 27, 3, pp. 341-344, (1976)
16. Luboshitzky R., Dickstein G., Barzilai D., Bromocriptine-induced pregnancy in an acromegalic patient, JAMA, 244, 6, pp. 584-586, (1980)
17. Husebye E.S., Pearce S.H., Krone N.P., Kampe O., Adrenal insufficiency, Lancet, 397, 10274, pp. 613-629, (2021)
18. Bensing S., Giordano R., Falorni A., Fertility and pregnancy in women with primary adrenal insufficiency, Endocrine, 70, 2, pp. 211-217, (2020)
19. Anand G., Beuschlein F., Management of endocrine disease: Fertility, pregnancy and lactation in women with adrenal insufficiency, Eur J Endocrinol, 178, 2, (2018)
20. Petersenn S., Secondary adrenal insufficiency in pregnancy: Any differences?, Minerva Endocrinol, 43, 4, pp. 446-450, (2018)
21. Langlois F., Lim D.S.T., Fleseriu M., Update on adrenal insufficiency: Diagnosis and management in pregnancy, Curr Opin Endocrinol Diabetes Obes, 24, 3, pp. 184-192, (2017)
22. Glezer A., Jallad R.S., Machado M.C., Fragoso M.C., Bronstein M.D., Pregnancy and pituitary adenomas, Minerva Endocrinol, 41, 3, pp. 341-350, (2016)
23. Glezer A., Bronstein M.D., Prolactinomas in pregnancy: Considerations before conception and during pregnancy, Pituitary, 23, 1, pp. 65-69, (2020)
24. Cornejo M., Fuentes G., Valero P., Vega S., Grismaldo A., Toledo F., Et al., Gestational diabesity and foetoplacental vascular dysfunction, Acta Physiol (Oxf), 232, (2021)
25. Dicuonzo F., Purciariello S., De Marco A., Guastamacchia E., Triggiani V., Inoperable giant growth hormone-secreting pituitary adenoma: Radiological aspects, clinical management and pregnancy outcome, Endocr Metab Immune Disord Drug Targets, 19, 2, pp. 214-220, (2019)
26. Muhammad A., Neggers S.J., Van Der Lely A.J., Pregnancy and acromegaly, Pituitary, 20, 1, pp. 179-184, (2017)
27. Vila G., Jorgensen J.O.L., Luger A., Stalla G.K., Insulin resistance in patients with acromegaly, Front Endocrinol (Lausanne), 10, (2019)
28. Hannon A.M., Thompson C.J., Sherlock M., Diabetes in patients with acromegaly, Curr Diab Rep, 17, 2, (2017)
29. Dutta P., Hajela A., Gupta P., Rai A., Sachdeva N., Mukherjee K.K., Et al., The predictors of recov­ery from diabetes mellitus following neurosurgical treatment of acromegaly: A prospective study over a decade, Neurol India, 67, 3, pp. 757-762, (2019)
30. Atmaca A., Dagdelen S., Erbas T., Follow-up of pregnancy in acromegalic women: Different presentations and outcomes, Exp Clin Endocrinol Diabetes, 114, 3, pp. 135-139, (2006)
31. 14. Management of diabetes in pregnancy, Diabetes Care, 44, (2021)
32. Petrossians P., Daly A.F., Natchev E., Maione L., Blijdorp K., Sahnoun-Fathallah M., Et al., Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database, Endocr Relat Cancer, 24, 10, pp. 505-518, (2017)
33. Colao A., Ferone D., Marzullo P., Lombardi G., Systemic complications of acromegaly: Epidemi­ology, pathogenesis, and management, Endocr Rev, 25, 1, pp. 102-152, (2004)
34. Fleseriu M., Medical treatment of acromegaly in pregnancy, highlights on new reports, Endocrine, 49, 3, pp. 577-579, (2015)
35. 10. Cardiovascular disease and risk management, Diabetes Care, 44, (2021)
36. Lopez-Garcia R., Abarca-Olivas J., Monjas-Canovas I., Pico Alfonso A., Moreno-Lopez P., Gras­Albert JR. Endonasal endoscopic surgery in pituitary adenomas: Surgical results in a series of 86 consecutive patients, Neurocirugia (Astur), 29, 4, pp. 161-169, (2018)
37. Asha M.J., Takami H., Velasquez C., Oswari S., Almeida J.P., Zadeh G., Et al., Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: Single­center results, J Neurosurg, pp. 1-11, (2019)
38. Shen M., Tang Y., Shou X., Wang M., Zhang Q., Qiao N., Et al., Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center, World Neurosurg, 27, (2018)
39. Taghvaei M., Sadrehosseini S.M., Ardakani J.B., Nakhjavani M., Zeinalizadeh M., Endoscopic endonasal approach to the growth hormone-secreting pituitary adenomas: Endocrinologic out­come in 68 patients, World Neurosurg, 117, (2018)
40. Herman-Bonert V., Seliverstov M., Melmed S., Pregnancy in acromegaly: Successful therapeutic outcome, J Clin Endocrinol Metab, 83, 3, pp. 727-731, (1998)
41. Teltayev D., Akshulakov S., Ryskeldiev N., Mustafin K., Vyacheslav L., Pregnancy in women after successful acromegaly treatment, including surgical removal of pituitary adenoma and postoperative therapy using lanreotide acetate, Gynecol Endocrinol, 33, pp. 50-51, (2017)
42. Graillon T., Cuny T., Castinetti F., Courbiere B., Cousin M., Albarel F., Et al., Surgical indications for pituitary tumors during pregnancy: A literature review, Pituitary, 23, 2, pp. 189-199, (2020)
43. Gonzalez J.G., Elizondo G., Saldivar D., Nanez H., Todd L.E., Villarreal J.Z., Pituitary gland growth during normal pregnancy: An in vivo study using magnetic resonance imaging, Am J Med, 85, 2, pp. 217-220, (1988)
44. Dinc H., Esen F., Demirci A., Sari A., Resit Gumele H., Pituitary dimensions and volume mea­surements in pregnancy and post partum. MR assessment, Acta Radiol, 39, 1, pp. 64-69, (1998)
45. Bronstein M.D., Paraiba D.B., Jallad R.S., Management of pituitary tumors in pregnancy, Nat Rev Endocrinol, 7, 5, pp. 301-310, (2011)
46. Kasuki L., Neto L.V., Takiya C.M., Gadelha M.R., Growth of an aggressive tumor during preg­nancy in an acromegalic patient, Endocr J, 59, 4, pp. 313-319, (2012)
47. Grand'Maison S., Weber F., Bedard M.J., Mahone M., Godbout A., Pituitary apoplexy in preg­nancy: A case series and literature review, Obstet Med, 8, 4, pp. 177-183, (2015)
48. Muthukumar N., Pituitary apoplexy: A comprehensive review, Neurol India, 68, (2020)
49. Chen C.J., Ironside N., Pomeraniec I.J., Chivukula S., Buell T.J., Ding D., Et al., Microsurgical ver­sus endoscopic transsphenoidal resection for acromegaly: A systematic review of outcomes and complications, Acta Neurochir, 159, 11, pp. 2193-2207, (2017)
50. Lesen E., Granfeldt D., Houchard A., Dinet J., Berthon A., Olsson D.S., Et al., Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: A register-linkage population­based study, Eur J Endocrinol, 176, 2, pp. 203-212, (2017)
51. Fleseriu M., Biller B.M.K., Freda P.U., Gadelha M.R., Giustina A., Katznelson L., Et al., A pituitary society update to acromegaly management guidelines, Pituitary, 24, 1, pp. 1-13, (2021)
52. Levine M., O'Connor A.D., Obstetric toxicology: Teratogens, Emerg Med Clin North Am, 30, 4, pp. 977-990, (2012)
53. Hannon A.M., Frizelle I., Kaar G., Hunter S.J., Sherlock M., Thompson C.J., Et al., Octreotide use for rescue of vision in a pregnant patient with acromegaly, Endocrinol Diabetes Metab Case Rep, 2019, (2019)
54. Maffei P., Tamagno G., Nardelli G.B., Videau C., Menegazzo C., Milan G., Et al., Effects of octreo­tide exposure during pregnancy in acromegaly, Clin Endocrinol, 72, 5, pp. 668-677, (2010)
55. Brian S.R., Bidlingmaier M., Wajnrajch M.P., Weinzimer S.A., Inzucchi S.E., Treatment of acro­megaly with pegvisomant during pregnancy: Maternal and fetal effects, J Clin Endocrinol Metab, 92, 9, pp. 3374-3377, (2007)
56. Van Der Lely A.J., Gomez R., Heissler J.F., Akerblad A.C., Jonsson P., Camacho-Hubner C., Et al., Pregnancy in acromegaly patients treated with pegvisomant, Endocrine, 49, 3, pp. 769-773, (2015)
57. Persechini M.L., Gennero I., Grunenwald S., Vezzosi D., Bennet A., Caron P., Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph func­tion, Pituitary, 18, 4, pp. 461-464, (2015)
58. Wiesli P., Zwimpfer C., Zapf J., Schmid C., Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile sub­unit (ALS) in patients with growth hormone (GH) deficiency and excess, Acta Obstet Gynecol Scand, 85, 8, pp. 900-905, (2006)
59. Lau S.L., McGrath S., Evain-Brion D., Smith R., Clinical and biochemical improvement in acro­megaly during pregnancy, J Endocrinol Investig, 31, 3, pp. 255-261, (2008)
60. Yang M.J., Tseng J.Y., Chen C.Y., Yeh C.C., Changes in maternal serum insulin-like growth fac­tor-I during pregnancy and its relationship to maternal anthropometry, J Chin Med Assoc, 76, 11, pp. 635-639, (2013)
61. Cheng V., Faiman C., Kennedy L., Khoury F., Hatipoglu B., Weil R., Et al., Pregnancy and acro­megaly: A review, Pituitary, 15, 1, pp. 59-63, (2012)